AZ HB2434

Requires medical practitioners to obtain a patient utilization report from the controlled substances prescription monitoring program before prescribing opioid analgesics or benzodiazepines (schedules II-IV) and before each subsequent refill, replacing the previous requirement of checking only at the beginning of treatment and quarterly thereafter

Renames the prescription monitoring program "task force" to "compliance workgroup" and refocuses its purpose from supporting electronic prescribing adoption to identifying potential noncompliance with program usage requirements

Removes references to tracking "consumption" of controlled substances, limiting the database to monitoring only prescribing and dispensing activities

Changes law enforcement access requirements from requiring an "affidavit" to requiring a valid "search warrant" for open investigations, and strengthens privacy protections for dispensing data

Expands delegate definitions to clarify that pharmacy technicians and interns must be employed by a pharmacy or hospital in Arizona, and updates language regarding employment relationships for authorized delegates